Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
19 results
D3.339 - Severe β-lactam hypersensitivity phenotypes in routine care: anaphylaxis frequency in a 22-centre outpatient survey in China
D3.340 - The importance of de-labeling contrast allergy în cardiology department - clinical case
D3.341 - Alignment with International Anaphylaxis Management Guidelines in a Tertiary Referral Center in Central Asia: A Retrospective Clinical Audit
D3.342 - Adverse Events of Biologic Therapies: A One-Year Retrospective Study
D3.343 - Hereditary alpha-tryptasemia: clinical variability and anaphylaxis triggers in six genetically confirmed cases
D3.344 - Rapid Desensitization to Iohexol Following Iopamidol-Induced Anaphylaxis Prior to Urgent Coronary Angiography
D3.345 - Anaphylactic Shock: Clinical Analysis of 8 Cases with Post-Hospital Outpatient Follow-Up
D3.346 - From Anaphylaxis to Oral Allergy Syndrome: Multiple Seed Hypersensitivity in a Single Pediatric Patient
D3.347 - Idiopathic Anaphylaxis: A Diagnostic Challenge
D3.348 - Alpha‑gal Syndrome in Young People: A Call for Public Health Awareness in Tick‑Endemic Areas of Scotland and North East England
D3.349 - Takotsubo cardiomyopathy triggered by anaphylaxis after a honey bee sting, forming ATAK complex: a rare case report
D3.351 - A case of Kounis syndrome in idiopathic anaphylaxis and indolent systemic mastocytosis
D3.352 - Long-term analytical stability of ImmunoCAP tryptase supports enduring clinical interpretation thresholds
D3.353 - Clinical Characteristics and Triggers of Pediatric Anaphylaxis Cases: A Retrospective Single-Center Experience
- D3.545 - Natural Killer and Dendritic Cells Leverage Synergistic Interactions to Enhance Treatment of Non-Small Cell Lung Cancer
- D3.544 - Allergic biomarkers and clinical outcomes in lung cancer patients treated with immune checkpoint inhibitors: a pilot study
- D3.546 - AllergoOncology: Basophil number and subpopulation proportions may offer potential as predictive biomarkers in non-small cell lung cancer
- D3.547 - Clinical Outcomes and Safety of Drug Desensitization in Chemotherapy-Induced Hypersensitivity
- D3.548 - Refractory and persistent pruritus in an atopic patient: A red flag for underlying malignancy?
Download the app
The congress at your fingertips
Available on
Download